|
 |
| 1-4
September, 2006 Pragati Maidan, New Delhi, India |
 |
|
|
Zenotech Gets Marketing Nod For Cancer Drug
Product to be lauched in the next few days
Zenotech Laboratories has received marketing approval for 'GM-CSF' and 'G-CSF', its generic versions for treating blood disorder in cancer patients and will launch both the products in India in the next few days.
'GM-CSF' and 'G-CSF' are the generic versions of Novartis' 'Leucomax' and Amgen/Roche's 'Neupogen' respectively and are used by oncology specialists to treat neutropenia in cancer patients, the company informed Bombay Stock Exchange.
The company is in discussions with potential partners to take its G-CSF to the European Union.
Scientists from Drugs Controller General of India (DGCI) and National Institute of Biologics have inspected the company's biologics manufacturing facility, which meets USFDA and EU specifications.
Date: 08-Aug-2006
Back
|
|
 |
|
|
|
 |
